glp‑1 refill strategy
Slash Prescription Weight Loss Bills by 30%
Patients can cut their prescription weight-loss costs by about 30% by using a structured refill strategy that switches from semaglutide to tirzepatide at the right time and leverages payer programs. A 2025 cost-analysis study found that leveraging pharmacy benefit managers can lower the annual cost of a semaglutide regimen by